(Q37945595)

25 August 2017

title

Role of haloperidol in palliative medicine: an update (English)

1 reference

25 August 2017

1 reference

Eric Prommer

1

1 reference

25 August 2017

publication date

13 October 2011

1 reference

American Journal of Hospice and Palliative Medicine

25 August 2017

published in

1 reference

25 August 2017

volume

29

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

295-301

1 reference

The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Pharmacokinetics of haloperidol: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Haloperidol kinetics after oral and intravenous doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Pharmacokinetics of droperidol in healthy volunteers following intravenous infusion and rectal administration from an osmotic drug delivery module

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Involvement of CYP3A4 and CYP2D6 in the metabolism of haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Protein Binding and Kinetics of Drugs in Liver Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

A double-blind study of adjunctive sertraline in haloperidol-stabilized patients with chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Antipsychotic medication and seizures: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Effects of psychotropic drugs on seizure threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Neuropsychiatric complications of commonly used palliative care drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

A double-blind trial of risperidone and haloperidol for the treatment of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Olanzapine vs haloperidol: treating delirium in a critical care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Intractable hiccups during stroke rehabilitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Sedation for refractory symptoms of terminal cancer patients in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Haloperidol in palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Neuroleptic dose in the management of delirium in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Subcutaneous infusions for control of cancer symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1049909111423094

21 January 2018

Identifiers

DOI

10.1177/1049909111423094

1 reference

25 August 2017

1 reference